*EMBARGOED All research presented at the 2022 ACG Annual Scientific Meeting and Postgraduate Course is strictly embargoed until Sunday, October 23, 2022, at 12:00 pm EDT.

Simone Peters, PhD
Simone Peters, PhD

Oral 15 – App-Delivered Gut-Directed Hypnotherapy Program Nerva Improves Symptoms in Patients With Irritable Bowel Syndrome but How Can We Ensure Users Are Compliant?

Monday, October 24, 2022 | 2:15 PM – 2:25 PM ET | Location: Hall C1

Author Insight from Simone Peters, PhD, Monash University

What’s new here and important for clinicians?

Gut-directed hypnotherapy improves overall and individual gastrointestinal symptoms in ~70% of patients with IBS. The effects are not due to a placebo response and are maintained up to 5 years post-treatment. Access to suitably trained hypnotherapists is limited and therapy can be expensive. Digital app-delivered gut-directed hypnotherapy is similarly as efficacious as face-to- face therapy and allows for greater access at a notably reduced cost. Patients who use app- delivered gut-directed hypnotherapy as equally likely to respond regardless of whether they find the app on their own or are referred by a health care provider (HCP, but HCP enhances program completion rates. IBS patients referred to app-delivered gut-directed hypnotherapy by an HCP are more compliant.

What do patients need to know?

Read the Abstract

Author Contact
Simone Peters, PhD, Monash University
simone.peters [at] monash.edu

Media Interview Requests
To arrange an interview with any ACG experts or abstract authors, please contact Becky Abel of ACG via email at mediaonly [at] gi.org or by phone at 301-263-9000.